Key opportunities in the chemical licensing market are driven by demand in advanced manufacturing, particularly in the C2 value chain and the pharmaceutical sector. The Asia-Pacific region leads ...

For many adults, weight management doesn’t feel like a simple equation of diet and discipline. Sluggish digestion, persistent cravings, and uncomfortable bloating can make everyday choices feel harder ...

Global capability centres (GCCs) have evolved far beyond their origins as cost-efficiency engines, writes Shobana Maikoo, ...

EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced p ...